Synuclav 50mg Tablets for Dogs and Cats
Synuclav 50mg Tablets for Dogs and Cats
Not authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Synuclav 50mg Tablets for Dogs and Cats
Clavobay 50 mg comprimidos para cães e gatos
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Potassium clavulanate11.90/milligram(s)1.00Tablet
-
Amoxicillin trihydrate40.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Portugal
Package description:
- box containing 500 tablets (50 blister)
- box containing 20 tablets (2 blister)
- box containing 100 tablets (10 blister)
- box containing 1 bottle containing 500 tablets
- box containing 1 bottle containing 100 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Laboratories (Ireland) Limited
Responsible authority:
- Directorate General For Food And Veterinary
Authorisation number:
- 51526
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0349/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Portuguese (PDF)
Published on: 19/04/2024
Summary of Product Characteristics
English (PDF)
Download Published on: 22/10/2025
Package Leaflet
English (PDF)
Download Published on: 22/10/2025